Search PDMR transactions

Notifier
Name of person with notification obligation
Hangethe Consulting AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Patrik Fagerholm
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant NextCell Pharma AB TO2 SE0022240800 Acquisition 50,000 Quantity 0.08 SEK 09/05/2025 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma AB TO2 SE0022240800 Acquisition 09/05/2025 FIRST NORTH SWEDEN 50,000 (Quantity) 0.08 SEK
Total: 50,000
<< Back